<code id='D66283F0F0'></code><style id='D66283F0F0'></style>

<acronym id='D66283F0F0'></acronym>

<center id='D66283F0F0'><center id='D66283F0F0'><tfoot id='D66283F0F0'></tfoot></center><abbr id='D66283F0F0'><dir id='D66283F0F0'><tfoot id='D66283F0F0'></tfoot><noframes id='D66283F0F0'>

<optgroup id='D66283F0F0'><strike id='D66283F0F0'><sup id='D66283F0F0'></sup></strike><code id='D66283F0F0'></code></optgroup>

<b id='D66283F0F0'><label id='D66283F0F0'><select id='D66283F0F0'><dt id='D66283F0F0'><span id='D66283F0F0'></span></dt></select></label></b><u id='D66283F0F0'></u>

~~<i id='D66283F0F0'><strike id='D66283F0F0'><tt id='D66283F0F0'><pre id='D66283F0F0'></pre></tt></strike></i>~~

Home» comprehensive» comprehensive

comprehensive

comprehensive

author：leisure time 2025-10-02 11:56:14 Page View：34

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

LONDON — Novo Nordisk said Monday it would acquire the German firm Cardior Pharmaceuticals in a deal worth up to $1.1 billion, picking up additional drug candidates for its pipeline of cardiometabolic medicines.

Cardior focuses on targeting RNA to address the root causes of heart disease. Its lead candidate, known CDR132L, is in Phase 2 development as a treatment for health failure.

advertisement

The companies did not disclose how much Novo was paying upfront for Cardior and how much would be based on future milestones being achieved. The deal is expected to close in the second quarter.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： NYU Langone launches private ChatGPT for its health care data
Next article： The Supreme Court will review a ruling striking down a domestic violence federal gun ban

focus

In age of alternative facts, a scholarly course on calling out crap

In age of alternative facts, a scholarly course on calling out crap

Screenshotviacallingbullshit.orgTiredofalternativefacts,fakenews,andbreathlesshyperbole,twoprofessor

Novo acquires Inversago for up to $1 billion

Novo acquires Inversago for up to $1 billion

LISELOTTESABROE/Scanpix/AFPviaGettyImagesFreshoffofthenewsthatitsdrugWegovymaynotjusthelppeoplelosew

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

1:19Ademonstratorrunsonthethirdnightofprotestssparkedbythefatalpoliceshootingofa17-year-olddriverint

Why more medical students aren't specializing in primary care

AdobeTheU.S.isrunninglowonprimarycarephysicians,withanestimatedshortageofbetween17,800and48,000predi

read more